Literature DB >> 31774287

Dynamic Chirality in the Mechanism of Action of Allosteric CD36 Modulators of Macrophage-Driven Inflammation.

Emma Danelius1, Ragnhild G Ohm, Mukandila Mulumba, Huy Ong, Sylvain Chemtob1, Mate Erdelyi2,3, William D Lubell.   

Abstract

Dynamic chirality influences numerous processes in nature from protein folding to catalysis. Azapeptides are peptidomimetics possessing semicarbazide residues that can interconvert between sp2 and sp3 hybridization, resulting in stereodynamic interconversions of pseudo-R and -S-configurations by means of a planar intermediate. Cyclic azapeptides have shown unprecedented binding affinity to the cluster of differentiation 36 receptor (CD36) and ability to mitigate macrophage-driven inflammation by modulation of the toll-like receptor 2/6 pathway. A novel approach to synthesize cyclic peptides via A3-macrocyclization has been used to make R- and S-configuration controls to study the relevance of semicarbazide hybridization for modulator activity. Nuclear magnetic resonance spectroscopy analysis of potent cyclic azapeptide CD36 modulators (e.g., 1 and 2) and related cyclic peptides demonstrated that binding affinity correlated with conformational rigidity, and a hybridization preference for sp2 > S- > R-sp3 semicarbazide nitrogen configuration was evaluated. Evidence of the active conformation and the relevance for dynamic chirality serve as insights for creating cyclic (aza)peptide CD36 modulators to curb inflammation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31774287     DOI: 10.1021/acs.jmedchem.9b00918

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction.

Authors:  Fabio Begnini; Stefan Geschwindner; Patrik Johansson; Lisa Wissler; Richard J Lewis; Emma Danelius; Andreas Luttens; Pierre Matricon; Jens Carlsson; Stijn Lenders; Beate König; Anna Friedel; Peter Sjö; Stefan Schiesser; Jan Kihlberg
Journal:  J Med Chem       Date:  2022-02-02       Impact factor: 7.446

Review 2.  Tailoring Materials for Modulation of Macrophage Fate.

Authors:  Jinhua Li; Xinquan Jiang; Hongjun Li; Michael Gelinsky; Zhen Gu
Journal:  Adv Mater       Date:  2021-02-09       Impact factor: 32.086

Review 3.  Synthesis and Biomedical Potential of Azapeptide Modulators of the Cluster of Differentiation 36 Receptor (CD36).

Authors:  Caroline Proulx; Jinqiang Zhang; David Sabatino; Sylvain Chemtob; Huy Ong; William D Lubell
Journal:  Biomedicines       Date:  2020-07-23

4.  Solution Conformations Shed Light on PROTAC Cell Permeability.

Authors:  Yoseph Atilaw; Vasanthanathan Poongavanam; Caroline Svensson Nilsson; Duy Nguyen; Anja Giese; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  ACS Med Chem Lett       Date:  2020-12-25       Impact factor: 4.345

Review 5.  Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles.

Authors:  Dianqing Sun
Journal:  Molecules       Date:  2022-02-02       Impact factor: 4.411

6.  Employing complementary spectroscopies to study the conformations of an epimeric pair of side-chain stapled peptides in aqueous solution.

Authors:  Jonathan Bogaerts; Yoseph Atilaw; Stefan Peintner; Roy Aerts; Jan Kihlberg; Christian Johannessen; Máté Erdélyi
Journal:  RSC Adv       Date:  2021-01-20       Impact factor: 3.361

7.  Linker-Dependent Folding Rationalizes PROTAC Cell Permeability.

Authors:  Vasanthanathan Poongavanam; Yoseph Atilaw; Stephan Siegel; Anja Giese; Lutz Lehmann; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  J Med Chem       Date:  2022-09-28       Impact factor: 8.039

Review 8.  Polyamide Backbone Modified Cell Targeting and Penetrating Peptides in Cancer Detection and Treatment.

Authors:  Sunil S Shah; Nelson Casanova; Gina Antuono; David Sabatino
Journal:  Front Chem       Date:  2020-03-31       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.